한림대학교성심병원

서진원 교수

031-380-3937 jwseomd@hallym.or.kr
  • 진료과 병리과

전문진료분야

비뇨기병리, 신장병리, 이식병리, 폐병리

전화 예약 1577-1801
교수님사진

(주간) 진료시간표 (2021-10-18 ~ 2021-10-23)

진료시간표
진료시간
오전 해당 의료진의 지정된 스케쥴이 없습니다.
오후
교수님 사진

기본정보

학력

학력

1993.03 ~ 1999.02대구가톨릭대학교 의학 학사

2001.03 ~ 2003.02성균관대학교 의학 석사

경력

경력

2008.03 ~ 현) 한림대학교성심병원

2017.08 ~ 현) 한림대학교성심병원 병리과 임상과장

2000.03 ~ 2004.02삼성서울병원 전공의

2007.05 ~ 2008.02삼성서울병원 임상강사

학회활동

학회활동

대한병리학회

대한세포병리학회

논문

Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma (DIAGNOSTIC PATHOLOGY)

Ultrasound and MRI Findings of Giant Cell Fibroblastoma in the Abdominal Wall: Radiologic-Pathologic Correlations / 복벽에 발생한 거대세포 섬유아세포종의 초음파와 자기공명영상 소견: 영상소견과 병리학적 소견의 비교 (대한영상의학회지)

BRAF and NRAS mutations and antitumor immunity in Korean malignant melanomas and their prognostic relevance: Gene set enrichment analysis and CIBERSORT analysis (Pathology Research and Practice)

Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets (HUMAN PATHOLOGY)

Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in ALK-positive lung cancer: Comparison with EGFR-mutated lung cancer (Pathology Research and Practice)

Treatment for gastric 'indefinite for neoplasm/dysplasia' lesions based on predictive factors (WORLD JOURNAL OF GASTROENTEROLOGY)

Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations (BMC CANCER)

Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer (CANCER RESEARCH AND TREATMENT)

Clinical implication of programmed cell death-1 ligand-1 expression in tonsillar squamous cell carcinoma in association with intratumoral heterogeneity, human papillomavirus, and epithelial-to-mesenchymal transition (HUMAN PATHOLOGY)

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11 (GASTRIC CANCER)